Lin Su

Lin Su

Auto-generated profile, based on publicly available information

Lin Su

School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
ZXZi-Hang Xu
Zi-Hang Xu
YZYangzhuangzhuang Zhu
Yangzhuangzhuang Zhu
LSLin Su
Lin Su
XTXue-Yang Tang
Xue-Yang Tang
CYChao Yao
Chao Yao
CZChunpu Zou
Chunpu Zou
Non‐small‐cell lung cancer (NSCLC) remains the most common malignancy with the highest morbidity and mortality worldwide. In our previous study, we found that a classic traditional Chinese medicine (TCM) formula Ze‐Qi‐Tang (ZQT), which has been used in the treatment of respiratory diseases for thousands of years, could directly inhibit the growth of human NSCLC cells via the p53 signaling pathway. In this study, we explored the immunomodulatory functions of ZQT. We found that ZQT significantly prolonged the survival of orthotopic lung cancer model mice by modulating the tumor microenvironment (TME). ZQT remarkably reduced the number of MDSCs (especially G‐MDSCs) and inhibited their immunosuppressive activity by inducing apoptosis in these cells via the STAT3/S100A9/Bcl‐2/caspase‐3 signaling pathway. When G‐MDSCs were depleted, the survival promotion effect of ZQT and its inhibitory effect on lung luminescence signal disappeared in tumor‐bearing mice. This is the first study to illustrate the immunomodulatory effect of ZQT in NSCLC and the underlying molecular mechanism.